BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Radiology (1996) 69, 1159-1164
© 1996 British Institute of Radiology
doi:
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoskins, P. R.
Right arrow Articles by Ireland, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoskins, P. R.
Right arrow Articles by Ireland, H. M.

The British Journal of Radiology, Vol 69, Issue 828 1159-1164, Copyright © 1996 by British Institute of Radiology

ARTICLES

Patient dose measurements from femoral angiography

PR Hoskins, I Gillespie and HM Ireland
Department of Medical Physics, Royal Infirmary, Edinburgh, UK.

Investigation of patient dose from femoral angiography requires detailed logging of dose-area product (DAP) measurements, which is time-consuming and only possible on small numbers of patients. A simple model for the femoral angiogram study consists of two regions; lower limbs and torso. The experimental phantom was the abdominal and pelvic sections of a Rando phantom, and two 10 cm diameter water filled cylinders to represent a lower limb. DAP rate during screening, and the DAP per spot film exposure were obtained in two rooms. Total DAP values were measured on 100 patients in each room. The median screening time and number of spot film exposures were divided between the two regions. The DAP from screening and spot films for each region was estimated by combining the phantom and patient data. The total DAP predicted by the model agreed to within 7% of the median DAP from the patient studies Conversion to effective dose gave 9.0 mSv for the newer room compared with 2.8 mSv for the older room. In the newer room it was estimated that digital spot film exposure contributed 88% of the total effective dose. In the same room, exposure of the torso contributed 98% of the total effective dose. The model will enable interpretation of total DAP measurements made from femoral angiogram studies without the need for detailed DAP measurements on every patient. Attempts to reduce patient dose from femoral angiography must concentrate on reduction of the number and dose per exposure from abdominal and pelvic digital spot films.


This article has been cited by other articles:


Home page
 RadiologyHome page
F. A. Mettler Jr, W. Huda, T. T. Yoshizumi, and M. Mahesh
Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog
Radiology, July 1, 2008; 248(1): 254 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Radiat Prot DosimetryHome page
C. J. Martin
RADIATION DOSIMETRY FOR DIAGNOSTIC MEDICAL EXPOSURES
Radiat Prot Dosimetry, March 28, 2008; (2008) ncm495v1.
[Abstract] [Full Text] [PDF]

Home page
 Radiat Prot DosimetryHome page
L. Struelens, F. Vanhavere, H. Bosmans, R. Van Loon, and M. Geukens
Data analysis from a multi-centre, comparative study of angiographic examinations leading to practical guidelines for the optimisation of patient doses
Radiat Prot Dosimetry, December 1, 2005; 117(1-3): 87 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
D Bor, T Sancak, T Olgar, Y Elcim, A Adanali, U Sanlidilek, and S Akyar
Comparison of effective doses obtained from dose-area product and air kerma measurements in interventional radiology
Br. J. Radiol., April 1, 2004; 77(916): 315 - 322.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 1996 by the British Institute of Radiology.